C4 Therapeutics, Inc. (CCCC)
3.85
-0.25
(-6.10%)
USD |
NASDAQ |
Aug 28, 16:00
3.83
-0.02
(-0.52%)
After-Hours: 20:00
C4 Therapeutics Free Cash Flow : -85.39M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -85.39M |
| March 31, 2026 | -96.02M |
| December 31, 2025 | -99.30M |
| September 30, 2025 | -95.07M |
| June 30, 2025 | -87.58M |
| March 31, 2025 | -80.50M |
| December 31, 2024 | -65.34M |
| September 30, 2024 | -71.58M |
| June 30, 2024 | -78.76M |
| March 31, 2024 | -92.95M |
| Date | Value |
|---|---|
| December 31, 2023 | -108.55M |
| September 30, 2023 | -115.00M |
| June 30, 2023 | -115.02M |
| March 31, 2023 | -118.38M |
| December 31, 2022 | -111.44M |
| September 30, 2022 | -106.60M |
| June 30, 2022 | -93.63M |
| March 31, 2022 | -89.66M |
| December 31, 2021 | -88.24M |
| September 30, 2021 | -84.30M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Beam Therapeutics, Inc. | -372.77M |
| Rallybio Corp. | 26.71M |
| Q32 Bio, Inc. | -19.83M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.574M |
| Cash from Investing (Quarterly) | -14.82M |
| Cash from Financing (Quarterly) | 33.72M |
| Free Cash Flow Per Share (Quarterly) | -0.0123 |
| Free Cash Flow to Equity (Quarterly) | -0.022M |
| Free Cash Flow to Firm (Quarterly) | -1.611M |
| Free Cash Flow Yield | -19.89% |